Evidence map›Paper›PMID 42315712›Full record

ArticleCommunications biology2026

Vimentin promotes collective cell migration through collagen networks via increased matrix remodeling and spheroid fluidity.

Minh Tri Ho Thanh, Arun Poudel, Shabeeb Ameen, Bobby Carroll, M Wu, Pranav Soman, Tao Zhang, J M Schwarz, Alison E Patteson

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Vimentin - Force regulator in confined environments.Current opinion in cell biology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Minh Tri Ho ThanhPhysics Department, Syracuse University, Syracuse, NY, USA. mhothanh@syr.edu.ORCID http://orcid.org/0000-0002-9380-0191
Arun PoudelBioInspired Institute, Syracuse University, Syracuse, NY, USA.
Shabeeb AmeenPhysics Department, Syracuse University, Syracuse, NY, USA.
Bobby CarrollPhysics Department, Syracuse University, Syracuse, NY, USA.
M WuDepartment of Biological and Environmental Engineering, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0001-7846-3580
Pranav SomanBioInspired Institute, Syracuse University, Syracuse, NY, USA.
Tao ZhangDepartment of Polymer Science and Engineering, Shanghai Jiao Tong University, Shanghai, China.
J M SchwarzPhysics Department, Syracuse University, Syracuse, NY, USA.
Alison E PattesonPhysics Department, Syracuse University, Syracuse, NY, USA. aepattes@syr.edu.ORCID http://orcid.org/0000-0002-4004-1734

Funding

Microfluidic platform for tumor cell invasionR01CA221346 · NCI · CORNELL UNIVERSITY · PI Mingming Wu · 2017 to 2026
$3.4M
Role of vimentin in mammalian cell motilityR35GM142963 · NIGMS · SYRACUSE UNIVERSITY · PI PATTESON, ALISON ELISE · 2021 to 2025
$2.1M
TM/SC-interface-on-a-chip for mechanistic studies of outflow regulation.R21EY036189 · NEI · UPSTATE MEDICAL UNIVERSITY · PI HERBERG, SAMUEL · 2024 to 2025
$439k
Design of the Glomerulus and bOwman cApsuLe on a chip (GOAL)R21DK136083 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI KRENDEL, MIRA · 2023 to 2023
$435k
High-Throughput Single Cell MechanomicsR21GM141573 · NIGMS · SYRACUSE UNIVERSITY · PI SOMAN, PRANAV · 2021 to 2022
$430k
National Science Foundation (NSF) PoLS-2014192National Science Foundation (NSF) PoLS-2412961National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) 22303051NCI NIH HHS R01 CA221346NEI NIH HHS R21 EY036189NIDDK NIH HHS R21 DK136083NIGMS NIH HHS R21 GM141573NIGMS NIH HHS R35 GM142963U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21 DK136083-01A1U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21 EY036189-01U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21 GM141573-01U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35 GM142963U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01 CA221346-07
6 · The paper itself

Abstract

Intermediate filaments (IF) are diverse and cell-type specific. The IF protein vimentin, expressed in mesenchymal cells and different cancer cells, is functionally associated with cell migration through fibrous tissues. Vimentin increases cell elongation needed for migration, yet also acts as a cytoskeletal cage that hinders cells squeezing through small spaces. To determine how vimentin facilitates cell migration through the extracellular matrix (ECM) and around neighboring cells in tissues, we examine the collective invasion of cell spheroids embedded in collagen networks. Unlike single-cell migration in collagen networks, the collective invasion of cells through the collagen network is increased by vimentin for both mouse embryonic fibroblasts (MEF) and co-cultures of MEF with MDA-MB-231 breast cancer cells. Using multiple experimental systems, we show that vimentin increases spheroid contractility and that vimentin-mediated collective cell expansion depends on matrix metalloproteinases (MMP), which degrade collagen networks. In addition, through advanced imaging and a computational 3D cell vertex model, we find that vimentin enhances the elongation of cells in spheroids embedded in collagen, indicating increased spheroid fluidity and active collagen contraction. Altogether, these results reveal new insights on vimentin's effects in enhancing collective cell migration in 3D matrix environments through collagen remodeling and tissue fluidity.

Indexed as

Cell MovementCollagenExtracellular MatrixSpheroids, CellularVimentinAnimalsCoculture TechniquesFemaleFibroblastsHumansMDA-MB-231 CellsMiceCollagenVimentin

Identifiers

PMID42315712
PMCPMC13639091

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.